PeptidePicker
Home/Peptides/Humanin
Anti-AgingResearch

Humanin

Also known as: HN · Mitochondrial Peptide Humanin

A mitochondrial-derived peptide that protects against programmed cell death. Discovered in brains of Alzheimer's patients who resisted neural decay.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~30 minutes

Typical Dose

1–5 mg

Administration

Subcutaneous injection

Mechanism of Action

Binds to BAX and other pro-apoptotic proteins to block mitochondrial-mediated apoptosis, providing cellular cytoprotection under stress.

Key Research Areas

anti-agingneuroprotectivemitochondrialapoptosis

Frequently Asked Questions

What is Humanin?
A mitochondrial-derived peptide that protects against programmed cell death. Discovered in brains of Alzheimer's patients who resisted neural decay.
How does Humanin work?
Binds to BAX and other pro-apoptotic proteins to block mitochondrial-mediated apoptosis, providing cellular cytoprotection under stress.
What is the recommended dosage for Humanin?
The typical research dosage is 1–5 mg, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Humanin?
The half-life of Humanin is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Humanin FDA approved?
Humanin is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about Humanin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Anti-Aging